Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
Apr 25, 16:00
Stemcell Holdings Cash from Investing (TTM): -1.163M for Sept. 30, 2018
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| September 30, 2018 | -1.163M |
| June 30, 2018 | -1.203M |
| March 31, 2018 | -1.172M |
| December 31, 2017 | -0.6799M |
| Date | Value |
|---|---|
| September 30, 2017 | -0.78M |
| June 30, 2017 | -0.9265M |
| March 31, 2017 | -0.7716M |
| December 31, 2016 | -0.6008M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| AIM ImmunoTech Inc | -0.832M |
| Perspective Therapeutics Inc | 24.37M |
| Protalix BioTherapeutics Inc | -16.71M |
| Electromed Inc | -1.219M |
| Armata Pharmaceuticals Inc | -8.134M |